StepStone Group Inc. (STEP)
NASDAQ: STEP · Real-Time Price · USD
59.26
+1.81 (3.15%)
Aug 8, 2025, 12:39 PM - Market open

Ligand Pharmaceuticals Revenue

StepStone Group had revenue of $364.29M in the quarter ending June 30, 2025, with 95.43% growth. This brings the company's revenue in the last twelve months to $1.35B, up 87.87% year-over-year. In the fiscal year ending March 31, 2025, StepStone Group had annual revenue of $1.17B with 65.09% growth.

Revenue (ttm)
$1.35B
Revenue Growth
+87.87%
P/S Ratio
3.15
Revenue / Employee
$1,197,094
Employees
1,130
Market Cap
7.05B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20251.17B463.20M65.09%
Mar 31, 2024711.63M779.21M-1,153.11%
Mar 31, 2023-67.57M-1.43B-104.95%
Mar 31, 20221.37B577.81M73.35%
Mar 31, 2021787.72M341.11M76.38%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition